XBIOTECH INCXBIOTECH INCXBIOTECH INC

XBIOTECH INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪200.71 M‬EUR
−0.96EUR
‪−22.25 M‬EUR
0.00EUR
‪19.78 M‬
Beta (1Y)
1.24
Employees (FY)
82
Change (1Y)
−3 −3.53%
Revenue / Employee (1Y)
0.00EUR
Net income / Employee (1Y)
‪−271.33 K‬EUR

About XBiotech Inc.


CEO
John Simard
Headquarters
Austin
Founded
2005
FIGI
BBG008HB60N7
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4XB is 6.00 EUR — it has decreased by −2.29% in the past 24 hours. Watch XBIOTECH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange XBIOTECH INC stocks are traded under the ticker 4XB.
4XB stock has risen by 4.07% compared to the previous week, the month change is a −1.54% fall, over the last year XBIOTECH INC has showed a 56.25% increase.
4XB reached its all-time high on Jan 14, 2020 with the price of 22.64 EUR, and its all-time low was 2.80 EUR and was reached on Apr 27, 2023. View more price dynamics on 4XB chart.
See other stocks reaching their highest and lowest prices.
4XB stock is 6.67% volatile and has beta coefficient of 1.24. Track XBIOTECH INC stock price on the chart and check out the list of the most volatile stocks — is XBIOTECH INC there?
Today XBIOTECH INC has the market capitalization of ‪195.85 M‬, it has increased by 6.46% over the last week.
Yes, you can track XBIOTECH INC financials in yearly and quarterly reports right on TradingView.
XBIOTECH INC is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
4XB net income for the last quarter is ‪−4.50 M‬ EUR, while the quarter before that showed ‪−12.14 M‬ EUR of net income which accounts for 62.91% change. Track more XBIOTECH INC financial stats to get the full picture.
As of Dec 18, 2024, the company has 82.00 employees. See our rating of the largest employees — is XBIOTECH INC on this list?
Like other stocks, 4XB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XBIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So XBIOTECH INC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating XBIOTECH INC stock shows the sell signal. See more of XBIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.